TipRanks
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276)
:1276
Hong Kong Market
1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:1276 full AI Analyst Report?

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Ratios

9 Followers

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H Ratios

HK:1276's free cash flow for Q2 2026 was HK$0.84. For the 2026 fiscal year, HK:1276's free cash flow was decreased by HK$ and operating cash flow was HK$0.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Mar 24Mar 23
Liquidity Ratios
Current Ratio
 11.68 8.08 9.72 12.25 8.50
Quick Ratio
 10.98 7.63 9.05 11.34 7.82
Cash Ratio
 9.12 6.43 6.83 8.12 4.15
Solvency Ratio
 1.47 1.06 1.76 1.86 1.19
Operating Cash Flow Ratio
 2.11 1.76 2.04 3.01 0.35
Short-Term Operating Cash Flow Coverage
 13.07 0.00 0.00 13.87 0.80
Net Current Asset Value
HK$ 43.82BHK$ 48.30BHK$ 33.26BHK$ 31.46BHK$ 30.42B
Leverage Ratios
Debt-to-Assets Ratio
 0.01 <0.01 <0.01 0.01 0.04
Debt-to-Equity Ratio
 0.01 <0.01 <0.01 0.02 0.04
Debt-to-Capital Ratio
 0.01 <0.01 <0.01 0.02 0.04
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.10 1.14 1.10 1.08 1.12
Debt Service Coverage Ratio
 11.14 596.72 1.28K 8.96 2.78
Interest Coverage Ratio
 1.32K 626.53 1.35K 831.66 633.40
Debt to Market Cap
 <0.01 0.00 0.00 <0.01 <0.01
Interest Debt Per Share
 0.11 <0.01 0.01 0.11 0.30
Net Debt to EBITDA
 -4.43 -4.28 -3.11 -3.72 -2.90
Profitability Margins
Gross Profit Margin
85.34%86.21%86.25%84.55%83.61%
EBIT Margin
24.99%27.58%25.64%20.48%18.68%
EBITDA Margin
27.38%30.20%28.41%23.57%21.40%
Operating Profit Margin
23.92%28.42%26.77%21.52%19.33%
Pretax Profit Margin
27.48%27.53%25.62%20.45%18.65%
Net Profit Margin
24.67%24.38%22.64%18.85%18.36%
Continuous Operations Profit Margin
24.67%24.40%22.64%18.75%17.93%
Net Income Per EBT
89.75%88.56%88.38%92.19%98.43%
EBT Per EBIT
114.92%96.86%95.72%95.05%96.51%
Return on Assets (ROA)
10.92%11.04%12.64%9.88%9.35%
Return on Equity (ROE)
12.42%12.58%13.92%10.69%10.48%
Return on Capital Employed (ROCE)
11.26%14.16%16.11%11.97%10.77%
Return on Invested Capital (ROIC)
10.01%12.55%14.24%10.83%9.94%
Return on Tangible Assets
12.30%12.23%14.05%10.70%9.86%
Earnings Yield
2.48%1.85%1.93%1.36%1.26%
Efficiency Ratios
Receivables Turnover
 4.73 5.00 4.20 3.32 2.26
Payables Turnover
 2.26 1.92 1.96 2.79 2.38
Inventory Turnover
 1.53 1.52 1.59 1.52 1.42
Fixed Asset Turnover
 3.48 4.00 4.04 3.44 3.19
Asset Turnover
 0.44 0.45 0.56 0.52 0.51
Working Capital Turnover Ratio
 0.68 0.84 0.91 0.81 0.76
Cash Conversion Cycle
 153.86 123.87 129.59 218.64 264.73
Days of Sales Outstanding
 77.14 73.01 86.92 109.90 161.64
Days of Inventory Outstanding
 238.02 240.82 229.26 239.59 256.54
Days of Payables Outstanding
 161.30 189.96 186.59 130.85 153.45
Operating Cycle
 315.16 313.83 316.18 349.49 418.18
Cash Flow Ratios
Operating Cash Flow Per Share
 1.36 1.93 1.25 1.34 0.23
Free Cash Flow Per Share
 0.86 1.42 0.92 1.08 -0.13
CapEx Per Share
 0.50 0.51 0.33 0.26 0.35
Free Cash Flow to Operating Cash Flow
 0.63 0.74 0.73 0.81 -0.57
Dividend Paid and CapEx Coverage Ratio
 1.95 2.65 2.29 3.05 0.42
Capital Expenditure Coverage Ratio
 2.74 3.79 3.77 5.15 0.64
Operating Cash Flow Coverage Ratio
 12.38 259.44 107.52 12.22 0.75
Operating Cash Flow to Sales Ratio
 0.29 0.36 0.27 0.33 0.06
Free Cash Flow Yield
1.89%1.99%1.66%1.95%-0.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 40.00 54.09 52.03 73.28 79.38
Price-to-Sales (P/S) Ratio
 9.61 13.15 11.74 13.82 14.58
Price-to-Book (P/B) Ratio
 4.83 6.79 7.22 7.83 8.32
Price-to-Free Cash Flow (P/FCF) Ratio
 52.93 50.27 60.24 51.18 -426.60
Price-to-Operating Cash Flow Ratio
 34.77 37.01 44.26 41.25 245.09
Price-to-Earnings Growth (PEG) Ratio
 23.20 2.21 1.26 8.43 -4.02
Enterprise Value Multiple
 30.67 39.25 38.20 54.90 65.21
Enterprise Value
 263.08B 417.15B 323.13B 326.79B 338.12B
EV to EBITDA
 30.67 39.25 38.20 54.90 65.21
EV to Sales
 8.40 11.85 10.85 12.94 13.95
EV to Free Cash Flow
 46.25 45.32 55.70 47.93 -408.41
EV to Operating Cash Flow
 29.36 33.37 40.92 38.63 234.64
Tangible Book Value Per Share
 8.64 9.44 6.89 6.56 6.37
Shareholders’ Equity Per Share
 9.77 10.52 7.64 7.04 6.63
Tax and Other Ratios
Effective Tax Rate
 0.10 0.11 0.12 0.08 0.04
Revenue Per Share
 4.75 5.43 4.70 3.99 3.78
Net Income Per Share
 1.17 1.32 1.06 0.75 0.69
Tax Burden
 0.90 0.89 0.88 0.92 0.98
Interest Burden
 1.10 1.00 1.00 1.00 1.00
Research & Development to Revenue
 0.23 0.22 0.24 0.22 0.23
SG&A to Revenue
 0.38 0.23 0.26 0.28 0.29
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.16 1.46 1.17 1.79 0.33
Currency in HKD